Ephrin A1 ligand‐based CAR‐T cells for immunotherapy of EphA2‐positive cancer. - Liu, Nan; Wei, Wenwen; Ren, Kexing; Liang, Dandan; Yang, Dong; Zhang, Weishan; Yang, Beibei; Sun, Bin; Zhao, Jincheng; Cao, Dan; Zou, Liqun; Zhao, Xudong (Medcomm: Oncology, 2025)